» Articles » PMID: 38553638

Generation of Glioblastoma in Mice Engrafted with Human Cytomegalovirus-infected Astrocytes

Overview
Date 2024 Mar 30
PMID 38553638
Authors
Affiliations
Soon will be listed here.
Abstract

Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in glioblastoma multiforme (GB). Herewith, we present the first experimental evidence for the generation of CMV-Elicited Glioblastoma Cells (CEGBCs) possessing glioblastoma-like traits that lead to the formation of glioblastoma in orthotopically xenografted mice. In addition to the already reported oncogenic HCMV-DB strain, we isolated three HCMV clinical strains from GB tissues that transformed HAs toward CEGBCs and generated spheroids from CEGBCs that resulted in the appearance of glioblastoma-like tumors in xenografted mice. These tumors were nestin-positive mostly in the invasive part surrounded by GFAP-positive reactive astrocytes. The glioblastoma immunohistochemistry phenotype was confirmed by EGFR and cMet gene amplification in the tumor parallel to the detection of HCMV IE and UL69 genes and proteins. Our results fit with an HCMV-induced glioblastoma model of oncogenesis in vivo which will open the door to new therapeutic approaches and assess the anti-HCMV treatment as well as immunotherapy in fighting GB which is characterized by poor prognosis.

Citing Articles

Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies.

Zhang W, Zeng M, Li Y, Yu L Biomark Res. 2024; 12(1):71.

PMID: 39075601 PMC: 11287861. DOI: 10.1186/s40364-024-00617-6.


PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.

Wang J, Shen S, You J, Wang Z, Li Y, Chen Y Cell Death Dis. 2024; 15(7):524.

PMID: 39043634 PMC: 11266590. DOI: 10.1038/s41419-024-06920-2.


Cellular Transformation by Human Cytomegalovirus.

Herbein G Cancers (Basel). 2024; 16(11).

PMID: 38893091 PMC: 11171319. DOI: 10.3390/cancers16111970.


Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis.

Zhang H, Wang Z, Qiao X, Peng N, Wu J, Chen Y Mol Med. 2024; 30(1):91.

PMID: 38886655 PMC: 11184773. DOI: 10.1186/s10020-024-00857-0.

References
1.
Crawford L, Streblow D, Hakki M, Nelson J, Caposio P . Humanized mouse models of human cytomegalovirus infection. Curr Opin Virol. 2015; 13:86-92. PMC: 4599783. DOI: 10.1016/j.coviro.2015.06.006. View

2.
Herbein G . The Human Cytomegalovirus, from Oncomodulation to Oncogenesis. Viruses. 2018; 10(8). PMC: 6115842. DOI: 10.3390/v10080408. View

3.
Luo M, Hannemann H, Kulkarni A, Schwartz P, ODowd J, Fortunato E . Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J Virol. 2010; 84(7):3528-41. PMC: 2838134. DOI: 10.1128/JVI.02161-09. View

4.
Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y . Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition. Cancer Res. 2017; 78(1):230-245. PMC: 5754241. DOI: 10.1158/0008-5472.CAN-17-1961. View

5.
Kondo S, Wakisaka N, Muramatsu M, Zen Y, Endo K, Murono S . Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol. 2011; 85(21):11255-64. PMC: 3194961. DOI: 10.1128/JVI.00188-11. View